Interview: Lorenz Tanner on the SCI Patient Advisory Board and patient-centered research

The involvement of patients and their families is becoming increasingly important in clinical cancer research. Their experiences and perspectives help make studies more patient-centered and align research more closely with the needs of those affected.

In Universimeds journal "Hematology & Oncology", Lorenz Tanner, a member of the SCI Patient Council, discusses his personal motivation and his work as a patient advocate. In the interview, he explains why patients should be involved as early as the planning phase of clinical trials and what added value this collaboration offers to researchers and those affected.

The SCI Patient Advisory Board helps researchers make clinical trials more understandable and patient-centered. This includes, among other things, reviewing trial information to ensure that it is understandable even to people without a medical background. In addition, the Patient Advisory Board incorporates the perspectives of patients and their families early on in the development of new research projects.

The full interview provides insight into the evolution of patient advocacy in Switzerland and highlights why close collaboration between researchers and patients is crucial for the long-term advancement of clinical cancer research.